Development and validation of a multiplexed assay for the measurement of long-acting hormonal contraceptives in plasma via liquid chromatography-tandem mass spectrometry

Claire E. Knezevic, Teresa L. Parsons, Ryann Gollings, Aashish Pandey, Mark A. Marzinke

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Exogenous progestins are an effective tool for hormonal contraception and family planning. Progestins may be delivered as oral pills, intramuscular or subcutaneous injections, vaginal rings, or intrauterine devices. Drug concentrations may vary based on the route and duration of delivery. Measurement of synthetic steroids in blood plasma can aid in determination of product adherence, evaluation of drug-drug interactions, and investigation of unintended pregnancies. Methods: Drug-free K2EDTA plasma was spiked with the synthetic steroids etonogestrel (ETO), levonorgestrel (LNG), medroxyprogesterone acetate (MPA), and norethisterone (NET). Plasma was combined with isotopically labeled internal standards, and drugs were extracted via liquid-liquid extraction. Samples were then subjected to liquid chromatographic-tandem mass spectrometric (LC-MS/MS) analysis. The method was validated in accordance with regulatory recommendations. The assay was evaluated in a cohort of remnant plasma samples in individuals using one of the aforementioned progestins. Results: The analytical measuring range for ETO, MPA, and NET was 20–10,000 pg/mL; the primary linearity for LNG was 20–20,000 pg/mL. The method showed acceptable precision and accuracy for all progestins. Stability was established for 72 h with room temperature storage and through 3 freeze-thaw cycles. All analytes were stable in whole blood incubated at room temperature for 25 h, and at 40°C and 100% humidity for 2 h. Ion suppression was observed for all analytes spiked in plasma; average ion suppression was 31.6%, 66.6%, 32.1% and 41.2% for ETO, LNG, MPA, and NET, respectively. However, internal standards showed comparable ion suppression, and relative matrix effects were minimal. ETO, LNG, MPA, and NET could also be quantified accurately in K3EDTA plasma and serum. Progestins were successfully measured in remnant samples from individuals using hormonal contraceptives. Conclusions: A multiplexed LC-MS/MS assay for the quantification of ETO, LNG, MPA, and NET has been developed and validated. The assay met acceptable performance characteristics and may be used in downstream studies to evaluate progestin pharmacology.

Original languageEnglish (US)
Article number115321
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume228
DOIs
StatePublished - May 10 2023

Keywords

  • Etonogestrel
  • Hormonal contraceptives
  • LC-MS
  • Levonorgestrel
  • Mass spectrometry
  • Medroxyprogesterone acetate
  • Norethisterone
  • Progestins

ASJC Scopus subject areas

  • Drug Discovery
  • Analytical Chemistry
  • Spectroscopy
  • Clinical Biochemistry
  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Development and validation of a multiplexed assay for the measurement of long-acting hormonal contraceptives in plasma via liquid chromatography-tandem mass spectrometry'. Together they form a unique fingerprint.

Cite this